Haemonetics (HAE) Tops Q1 EPS by 1c, provides guidance
Tweet
Share
E-mailGet Alerts HAE Hot Sheet
Price: $107.60 --0%
EPS Growth %: 0.0%
Financial Fact:
Cost of goods sold: 116.01M
Today's EPS Names:
VIVO, OCCI, ALZN, More
EPS Growth %: 0.0%
Financial Fact:
Cost of goods sold: 116.01M
Today's EPS Names:
VIVO, OCCI, ALZN, More
Join SI Premium – FREE
Haemonetics (NYSE: HAE) reported Q1 EPS of $1.02, $0.01 better than the analyst estimate of $1.01. Revenue for the quarter came in at $336.17 million versus the consensus estimate of $335.05 million.
GUIDANCE:
Haemonetics sees FY2025 EPS of $4.45-$4.75, versus the consensus of $4.60.
For earnings history and earnings-related data on Haemonetics (HAE) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Citi upgrades Haemonetics to Buy, raises price target to $123
- HubSpot (HUBS) Reiterated at Hold by Stifel Amid Top-Line Uncertainty
- Janus Henderson names two senior equity portfolio managers
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
